Tandem Diabetes Care, Inc. (TNDM) financial statements and ratios from SEC XBRL: revenue $1.01B (TTM), net margin -20.2%, revenue growth 5.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.01B |
| Net Margin | -20.2% |
| Revenue Growth (YoY) | 5.5% |
| EPS Growth (YoY) | -84.8% |
| FCF Growth (YoY) | -122.5% |
| Price / Book | 11.69 |
| Price / Sales | 1.51 |
| FCF Yield | -0.2% |
| Altman Z-Score | 0.25 (distress) |
| Piotroski F-Score | 4/9 |
| Sector P/E (Healthcare) | 21.6 |
TNDM overview · TNDM earnings · TNDM KPIs · TNDM investor relations · TNDM ownership · TNDM peers · TNDM filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.